MedDataX Logo

Seroquel XR in the Long Term Treatment of Schizophrenia

NCT ID: NCT01202617

Last Updated: 2011-10-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1606 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-09-30

Study Completion Date

2011-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to determine whether the Seroquel XR treatment for 6 months improves the relapse prevention in schizophrenic outpatients

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Relapse in Schizophrenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Schizophrenic outpatients between 18 & 70 years of age

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* schizophrenic outpatients on at least 600 mg Seroquel XR treatment for at least 1 month

Exclusion Criteria

* Severe cerebro- and cardiovascular disease, severe hepatic impairment, gravidity
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Attila Nemeth

Role: PRINCIPAL_INVESTIGATOR

National Psychiatric Centre

Lilla Szabo

Role: STUDY_CHAIR

AstraZeneca

Alexandra Henringh

Role: STUDY_DIRECTOR

AstraZeneca

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

Baja, , Hungary

Site Status

Research Site

Balassagyarmat, , Hungary

Site Status

Research Site

Barcs, , Hungary

Site Status

Research Site

Berettyóújfalu, , Hungary

Site Status

Research Site

Budapest, , Hungary

Site Status

Research Site

Cegléd, , Hungary

Site Status

Research Site

Csongrád, , Hungary

Site Status

Research Site

Debrecen, , Hungary

Site Status

Research Site

Dombóvár, , Hungary

Site Status

Research Site

Dunaújváros, , Hungary

Site Status

Research Site

Eger, , Hungary

Site Status

Research Site

Emőd, , Hungary

Site Status

Research Site

Esztergom, , Hungary

Site Status

Research Site

Érd, , Hungary

Site Status

Research Site

Gödöllő, , Hungary

Site Status

Research Site

Gyöngyös, , Hungary

Site Status

Research Site

Győr, , Hungary

Site Status

Research Site

Gyula, , Hungary

Site Status

Research Site

Hajdusamson-Martinka, , Hungary

Site Status

Research Site

Hajdúszoboszló, , Hungary

Site Status

Research Site

Heves, , Hungary

Site Status

Research Site

Jánoshalma, , Hungary

Site Status

Research Site

Jászberény, , Hungary

Site Status

Research Site

Kalocsa, , Hungary

Site Status

Research Site

Karcag, , Hungary

Site Status

Research Site

Kecskemét, , Hungary

Site Status

Research Site

Kétegyháza, , Hungary

Site Status

Research Site

Kiskunhalas, , Hungary

Site Status

Research Site

Kiskunmajsa, , Hungary

Site Status

Research Site

Kistarcsa, , Hungary

Site Status

Research Site

Kistokaj, , Hungary

Site Status

Research Site

Komárom, , Hungary

Site Status

Research Site

Kozármisleny, , Hungary

Site Status

Research Site

Miskolc, , Hungary

Site Status

Research Site

Nagyatád, , Hungary

Site Status

Research Site

Nagykanizsa, , Hungary

Site Status

Research Site

Nagykálló, , Hungary

Site Status

Research Site

Nagykőrös, , Hungary

Site Status

Research Site

Ny�regyhaza, , Hungary

Site Status

Research Site

Pécs, , Hungary

Site Status

Research Site

Pomáz, , Hungary

Site Status

Research Site

Salgótarján, , Hungary

Site Status

Research Site

Sátoraljaújhely, , Hungary

Site Status

Research Site

Soltvadkert, , Hungary

Site Status

Research Site

Sopron, , Hungary

Site Status

Research Site

Szeged, , Hungary

Site Status

Research Site

Szeghalom, , Hungary

Site Status

Research Site

Szekszárd, , Hungary

Site Status

Research Site

Szentendre, , Hungary

Site Status

Research Site

Szentes, , Hungary

Site Status

Research Site

Székesfehérvár, , Hungary

Site Status

Research Site

Szigetszentmiklós, , Hungary

Site Status

Research Site

Szigetvár, , Hungary

Site Status

Research Site

Szolnok, , Hungary

Site Status

Research Site

Szombathely, , Hungary

Site Status

Research Site

Tata, , Hungary

Site Status

Research Site

Tatabánya, , Hungary

Site Status

Research Site

Tószeg, , Hungary

Site Status

Research Site

Vác, , Hungary

Site Status

Research Site

Veszprém, , Hungary

Site Status

Research Site

Zalegerszeg, , Hungary

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Hungary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIS-NHU-SER-2010/1

Identifier Type: -

Identifier Source: org_study_id